Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18726722rdf:typepubmed:Citationlld:pubmed
pubmed-article:18726722lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18726722lifeskim:mentionsumls-concept:C0030472lld:lifeskim
pubmed-article:18726722lifeskim:mentionsumls-concept:C0348026lld:lifeskim
pubmed-article:18726722lifeskim:mentionsumls-concept:C0439658lld:lifeskim
pubmed-article:18726722lifeskim:mentionsumls-concept:C0439858lld:lifeskim
pubmed-article:18726722lifeskim:mentionsumls-concept:C0449445lld:lifeskim
pubmed-article:18726722pubmed:issue7lld:pubmed
pubmed-article:18726722pubmed:dateCreated2008-8-26lld:pubmed
pubmed-article:18726722pubmed:abstractTextParaneoplastic neurological syndromes are important complications of cancer that are usually immune mediated. According to the clinical and immunological features, two groups of disorders can be considered. One group includes disorders mediated by antibodies against cell surface neuronal antigens; these syndromes often respond to treatment and have a favorable outcome. The other group includes disorders associated with antibodies against intracellular antigens; these syndromes are likely mediated by T-cell mechanisms, respond poorly to treatment, and have a less favorable outcome.lld:pubmed
pubmed-article:18726722pubmed:languagespalld:pubmed
pubmed-article:18726722pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18726722pubmed:citationSubsetIMlld:pubmed
pubmed-article:18726722pubmed:statusMEDLINElld:pubmed
pubmed-article:18726722pubmed:monthSeplld:pubmed
pubmed-article:18726722pubmed:issn0213-4853lld:pubmed
pubmed-article:18726722pubmed:authorpubmed-author:DalmasHHlld:pubmed
pubmed-article:18726722pubmed:authorpubmed-author:Gállego...lld:pubmed
pubmed-article:18726722pubmed:issnTypePrintlld:pubmed
pubmed-article:18726722pubmed:volume23lld:pubmed
pubmed-article:18726722pubmed:ownerNLMlld:pubmed
pubmed-article:18726722pubmed:authorsCompleteYlld:pubmed
pubmed-article:18726722pubmed:pagination441-8lld:pubmed
pubmed-article:18726722pubmed:meshHeadingpubmed-meshheading:18726722...lld:pubmed
pubmed-article:18726722pubmed:meshHeadingpubmed-meshheading:18726722...lld:pubmed
pubmed-article:18726722pubmed:meshHeadingpubmed-meshheading:18726722...lld:pubmed
pubmed-article:18726722pubmed:meshHeadingpubmed-meshheading:18726722...lld:pubmed
pubmed-article:18726722pubmed:meshHeadingpubmed-meshheading:18726722...lld:pubmed
pubmed-article:18726722pubmed:meshHeadingpubmed-meshheading:18726722...lld:pubmed
pubmed-article:18726722pubmed:meshHeadingpubmed-meshheading:18726722...lld:pubmed
pubmed-article:18726722pubmed:meshHeadingpubmed-meshheading:18726722...lld:pubmed
pubmed-article:18726722pubmed:meshHeadingpubmed-meshheading:18726722...lld:pubmed
pubmed-article:18726722pubmed:year2008lld:pubmed
pubmed-article:18726722pubmed:articleTitle[Classic paraneoplastic syndromes: diagnostic and treatment approach].lld:pubmed
pubmed-article:18726722pubmed:affiliationHospital de la Universidad de Pensilvania, Filadelfia, Estados Unidos.lld:pubmed
pubmed-article:18726722pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18726722pubmed:publicationTypeEnglish Abstractlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18726722lld:pubmed